UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.86B |
| 2 |
Prologis
PLD
|
+$1.82B |
| 3 |
Welltower
WELL
|
+$1.61B |
| 4 |
Microsoft
MSFT
|
+$1.53B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digital Realty Trust
DLR
|
+$822M |
| 2 |
AutoZone
AZO
|
+$481M |
| 3 |
Extra Space Storage
EXR
|
+$300M |
| 4 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$284M |
| 5 |
Meta Platforms (Facebook)
META
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.15% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.43% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.38B
| $1.65M | ﹤0.01% |
36,491
+35,444
| +3,385% | +$1.65M |
|
2127
Willdan Group
WLDN
$1.1B
| $1.65M | ﹤0.01% |
21,543
-1,412
| -6% | -$149K |
|
2128
Wave Life Sciences
WVE
$1.12B
| $1.63M | ﹤0.01% |
225,114
+60,129
| +36% | +$783K |
|
2129
Core Laboratories
CLB
$538M
| $1.63M | ﹤0.01% |
96,902
+1,704
| +2% | +$30.5K |
|
2130
Mission Produce
AVO
$1.1B
| $1.62M | ﹤0.01% |
117,857
-19,244
| -14% | -$256K |
|
2131
Gentherm
THRM
$1.31B
| $1.62M | ﹤0.01% |
58,326
+362
| +0.6% | +$11.8K |
|
2132
Independent Bank Corp
IBCP
$776M
| $1.62M | ﹤0.01% |
48,655
+452
| +0.9% | +$15.6K |
|
2133
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$749M
| $1.62M | ﹤0.01% |
39,661
+30,932
| +354% | +$1.3M |
|
2134
Asana
ASAN
$1.58B
| $1.62M | ﹤0.01% |
252,373
+28,007
| +12% | +$247K |
|
2135
Fulgent Genetics
FLGT
$559M
| $1.61M | ﹤0.01% |
101,303
+1,007
| +1% | +$21.9K |
|
|
FLY
2136
Firefly Aerospace
FLY
$3.23B
| $1.61M | ﹤0.01% |
+56,410
| New | +$1.37M |
|
2137
Deutsche Bank
DB
$66.3B
| $1.6M | ﹤0.01% |
53,811
+43,096
| +402% | +$1.52M |
|
2138
XPEL
XPEL
$1.18B
| $1.6M | ﹤0.01% |
36,193
+470
| +1% | +$22.5K |
|
2139
ING
ING
$93.8B
| $1.6M | ﹤0.01% |
61,378
+52,600
| +599% | +$1.48M |
|
2140
Greif Class B
GEF.B
$3.65B
| $1.6M | ﹤0.01% |
18,262
+2,623
| +17% | +$221K |
|
2141
Castle Biosciences
CSTL
$749M
| $1.59M | ﹤0.01% |
64,964
-4,664
| -7% | -$153K |
|
2142
Driven Brands
DRVN
$2.25B
| $1.59M | ﹤0.01% |
126,310
+23,290
| +23% | +$328K |
|
2143
PRA Group
PRAA
$648M
| $1.59M | ﹤0.01% |
90,746
+2,229
| +3% | +$33.9K |
|
2144
Tango Therapeutics
TNGX
$4.34B
| $1.58M | ﹤0.01% |
75,717
+34,264
| +83% | +$477K |
|
2145
American Express Global Business Travel
GBTG
$4.91B
| $1.58M | ﹤0.01% |
283,437
-31
| -0% | -$192 |
|
2146
Lloyds Banking Group
LYG
$87.4B
| $1.58M | ﹤0.01% |
313,567
+263,925
| +532% | +$1.45M |
|
2147
Genco Shipping & Trading
GNK
$1.17B
| $1.57M | ﹤0.01% |
69,423
+3,220
| +5% | +$68.9K |
|
2148
National Beverage
FIZZ
$2.87B
| $1.56M | ﹤0.01% |
46,414
+12,823
| +38% | +$445K |
|
2149
Employers Holdings
EIG
$908M
| $1.56M | ﹤0.01% |
37,851
+2,158
| +6% | +$91.2K |
|
2150
United States Antimony
UAMY
$766M
| $1.55M | ﹤0.01% |
177,813
+33,413
| +23% | +$291K |
|
Similar funds
UBS AM's Q1 2026 Portfolio in Review
As of Q1 2026, UBS AM held 3,871 positions worth $481B, up 1.7% from $473B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
UBS AM deployed $35.5B of net new capital in Q1 2026, opening 584 new positions and adding to 2,429 existing holdings. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 425,161 shares worth $49.8M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Digital Realty Trust, an estimated $822M trimmed.
- UBS AM's largest Q1 2026 buy was JPMorgan BetaBuilders US Equity ETF: 425,161 shares worth $49.8M.
- UBS AM added most to Broadcom in Q1 2026, an estimated $1.86B increase.
- UBS AM's biggest Q1 2026 reduction was Digital Realty Trust, cutting an estimated $822M.
- UBS AM fully exited CyberArk in Q1 2026, selling an estimated $139M.
- UBS AM's ten largest holdings make up 32% of its $481B portfolio in Q1 2026.
- UBS AM opened 584 new positions and closed 64 in Q1 2026.
- UBS AM's portfolio value rose 1.7% quarter-over-quarter to $481B.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.